Anti-CD44v6 Antibody (Bivatuzumab)
Catalog No.
F1494
Anti-CD44v6 Antibody (Bivatuzumab)
Featured Products
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody targeting CD44v6, which can be used as a sarcoma target for CAR-redirected CIK cells.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.22 kDa
Dry ice
214559-60-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ANTI-CD44
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P16070
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD44v6
Please avoid freeze-thaw cycles.